Michael Scolaro

Michael Scolaro

Oct 07, 2017

Group 6 Copy 217
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

How does sleep deprivation impact problematic eating?

Research studies have linked characteristics of eating disorders (e.g., binge eating, extreme dieting) with...

Can we biologically extend the range of human vision into the near infrared?

We have developed a protocol to augment human sight to see into the near infrared range through human formation...

Can we prevent the transmission of BRCA mutations?

Women with the BRCA gene mutation have an 80% risk of developing breast or ovarian cancer. Most research...

Backer Badge Funded